New 52 Week High Today

SIGA Technologies Inc SIGA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:53 PM EDT
8.60quote price arrow up+0.10 (+1.12%)
Volume
330,411
52 week range
3.93 - 8.70
Loading...
  • Open8.50
  • Day High8.70
  • Day Low8.40
  • Prev Close8.50
  • 52 Week High8.70
  • 52 Week High Date03/28/24
  • 52 Week Low3.93
  • 52 Week Low Date09/12/23

Key Stats

  • Market Cap611.033M
  • Shares Out71.09M
  • 10 Day Average Volume1.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change52.23

KEY STATS

  • Open8.50
  • Day High8.70
  • Day Low8.40
  • Prev Close8.50
  • 52 Week High8.70
  • 52 Week High Date03/28/24
  • 52 Week Low3.93
  • 52 Week Low Date09/12/23
  • Market Cap611.033M
  • Shares Out71.09M
  • 10 Day Average Volume1.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change52.23

RATIOS/PROFITABILITY

  • EPS (TTM)0.94
  • P/E (TTM)9.14
  • Fwd P/E (NTM)-
  • EBITDA (TTM)84.826M
  • ROE (TTM)37.09%
  • Revenue (TTM)139.917M
  • Gross Margin (TTM)87.69%
  • Net Margin (TTM)48.65%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date03/25/2024
  • Div Amount0.60
  • Split Date-
  • Split Factor-

Latest On SIGA Technologies Inc

 

Profile

MORE
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox...
Diem Nguyen Ph.D.
Chief Executive Officer, Director
Daniel Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Dennis Hruby Ph.D.
Executive Vice President, Chief Scientific Officer
Jay Varma M.D.
Executive Vice President, Chief Medical Officer, Director
Address
31 East 62Nd Street
New York, NY
10065
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
2.61-0.01-0.38%
TVTX
Travere Therapeutics Inc
7.88+0.21+2.80%
HROW
Harrow Inc
13.16+0.43+3.37%
CSTL
Castle Biosciences Inc
21.98+0.70+3.31%
AQST
Aquestive Therapeutics Inc
4.39+0.29+7.00%